Weakly immunogenic CRISPR therapies.
Nature biomedical engineering, 3(10): 761-762 PMID 31591524 DOI 10.1038/s41551-019-0463-7
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.